Somerset Berkley Regional High School celebrates its top 10 graduating seniors from the Class of 2026 and their impressive ...
Genomics launches the Mystra AI platform, adopted by industry giants and up-and-coming biotechs: London, England Wednesday, June 3, 2026, 12:00 Hrs [IST] Genomics, a science-led T ...
Largest cellular study of gut tissue unveils the genes and pathways driving inflammatory bowel disease, suggesting new therapeutic targets.
MADURAI: Teachers have urged the Tamil Nadu government to revise and streamline the State Board syllabus in line with the National Council of Educational Resear ...
Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating ...
Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, ...
A placebo-controlled clinical trial showed that semaglutide influenced epigenetic aging markers, telomere length, and other ...
A team at the Larner College of Medicine at the University of Vermont has stumbled onto a finding that upends a long-standing ...
Edex Live on MSN
Teachers urge curriculum overhaul to match NCERT standards
MADURAI: Teachers have urged the Tamil Nadu government to revise and streamline the State Board syllabus in line with the ...
Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed. Advances in ...
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results